OCTOBER 2018 | BRINGING INNOVATIONS TO MARKET | A publication of Purdue Research Foundation
Purdue TechTransfer Express
International companies take notice of Purdue startups; nine now acquired for strength of technology, business potential 

When Endocyte inked a $2.1 billion acquisition deal Thursday (Oct. 18) to be purchased by Swiss pharmaceutical giant Novartis AG, it became the ninth Purdue University startup to be bought by a major national or international company. Many other Purdue startups have had license and sublicense agreements with established corporations.

Simple stickers may save lives of heart patients, athletes and lower medical costs for families
Heart surgery can be traumatic for patients. Having to continuously monitor your status without a doctor when you are back home can be even scarier. Imagine being able to do that with a simple sticker applied to your body.

Cancer researchers at Purdue aim to take the ‘accelerator’ off aggressive prostate and other deadly tumors

Purdue University researchers are studying ways to make prostate cancer, ranked as the second most common and second most fatal cancer among men by the American Cancer Society, less lethal by making it less aggressive.

Purdue drug discovery aims to find better drug ‘fits,’ avoid medication tragedies like thalidomide 

When a medication doesn’t “fit” the body quite right, the results can be devastating. Such is the case for thalidomide, which was prescribed in the 1950s and 1960s as a sedative or hypnotic, even for pregnant women. Purdue University researchers, including chemistry professor and Nobel Prize winner Ei-ichi Negishi, have developed technology to create a new chemical process to synthesize drug-like molecules with ultra-high purity.   

Faster, liquid biopsies could replace invasive, tissue cancer detections

Tests to determine if you have cancer can be frightening, uncomfortable and time-consuming. Now, Purdue University researchers have developed and are commercializing a new method that could make early detection of cancer and other diseases easier, faster and less agonizing for patients. 

Nonaddictive drug compound could replace opioids for chronic pain sufferers

A new nonaddictive drug compound discovered by Purdue University researchers could lead to the treatment of chronic pain without the need to rely on opioids, just as a bipartisan package of bills moves through the U.S. House and Senate to battle the nation’s opioid epidemic.

A life-changing trip: Purdue alum working to reduce deaths from AIDS-related infection after visiting Kenya

What Purdue University alumnus Alexander Mills saw during his pharmacy student service-learning project in Kenya changed his career path. Now, he is on a journey to reduce the morbidity from Kaposi Sarcoma, one of AIDS’ most debilitating opportunistic infections.

Ultra-sensitive naval electric field sensor uses advanced materials 

Purdue University researchers have discovered a new sensing material to detect electric fields emitted by marine animals and manmade vessels, e.g. ships, naval vessels, in aqueous environments, including oceanic conditions.  The sensor maintains functional stability and does not corrode in saltwater.  It is highly sensitive and has low energy consumption.  Potential applications include the study of organisms and ecosystems, the monitoring of the movement of ships, and the location of objects in the ocean. 

New lithium-ion conductor could impact field of energy storage 

Researchers at Purdue University have developed a new solid-state thin film lithium ionic conductor made of perovskite nickelate thin film materials. This high performing design is comparable or better than the best reported perovskite type Li-ion conductor at room temperature. Energy storage industries who want reliable LIBs with enhanced electrolyte performance and a convenient fabrication process would benefit from this technology. It is anticipated that this could have a major impact in the field of batteries and energy storage

Manufacturing semiconducting polymer blends for organic transistors

Researchers at Purdue University have identified a new method for manufacturing polymer conductors that is both more stable than the predecessor, but also less expensive. This new development uses melt-processing, similar to how thin films such as plastic bags are made. This advancement in production allows for reduced costs of these organic transistors and there reduced flexible electronic costs.

Click here for more information on these and other Purdue technologies >>

Spotlight on Riyi Shi...

Riyi Shi is a medical scientist specializing in uncovering the mechanisms of central nervous system trauma and diseases and instituting new treatments through innovative experimentation and pioneering new strategies in the field. His research contributions includes originating the use of double sucrose gap technique for recording action potential conduction, establishing the methods of neuronal membrane resealing by polyethelyne glycol (PEG), and identifying acrolein as a key pathological factor in spinal cord injury and multiple sclerosis.

His research interests also include using nanotechnology to improve drug delivery to nervous tissue and incorporating biomedical engineering principles to enhance neuronal repair and diagnosis. This includes designing innovative scaffolds to enhance neuronal regeneration and using bioadhesives for neuronal tissue repair.

His laboratory is interested in the cellular and molecular underlying mechanism of nerve damage and recovery, particularly responses of the mammalian spinal cord following mechanical injury.

Learn more>>

Purdue Office of Technology Commercialization
Like what you read?

Share this email on...

Email   Facebook   Twitter   LinkedIn

Kurz Purdue Technology Center
1281 Win Hentschel Blvd.
West Lafayette, IN 47906
www.otc-prf.org | innovation@prf.org